Report Highlights

Strontium Market Overview in the United States

The U.S. strontium market was valued at USD 212 million in 2024 and is forecast to reach USD 291 million by 2032, a CAGR of 4.0%. Demand concentrates in four applications: strontium ferrite permanent magnets, red pyrotechnic colourants, ceramics and glass, and strontium-89 chloride for bone-pain palliation. The United States mines no celestite at commercial scale, so the market rests on imported celestite ore and strontium carbonate that arrive chiefly from Mexico and China.

Policy, rather than price alone, has defined the market's current form. Federal authority dominates the regulated edges: the Department of Defense stockpile, ATF explosives licensing, and NRC and FDA control of radiopharmaceuticals. Private firms lead magnet fabrication, fine-chemical distribution and pyrotechnic manufacturing, where government sets compliance conditions rather than volumes. Domestic carbonate refining has largely migrated offshore, leaving distribution and end-use manufacturing as the private sector's core strengths.

Policy-Driven Demand for U.S. Strontium

Three mechanisms drive demand. First, Section 301 tariffs administered by the Office of the U.S. Trade Representative on Chinese goods raised landed costs of imported ferrite magnets and magnet inputs, shifting motor and loudspeaker makers toward domestic assembly and non-Chinese carbonate. Second, the Inflation Reduction Act's Section 45X advanced manufacturing production credit supports processed critical-mineral and magnet output, improving the economics of domestic carbonate and magnet lines.

Third, the Section 232 investigation into processed critical minerals and derivative products, initiated by the Department of Commerce in April 2025, signals restrictions on refined imports. Each mechanism converts policy into demand through cost and procurement signals: tariffs raise import prices, credits lower domestic production costs, and the investigation pushes buyers to qualify secondary suppliers before duties take effect. Radiopharmaceutical demand grows separately under FDA approval and NRC licensing.

Regulatory Barriers and Compliance Costs

Explosives and pyrotechnic compositions fall under the Bureau of Alcohol, Tobacco, Firearms and Explosives, which requires a Federal Explosives License under 27 CFR Part 555 before manufacture or storage of flare compositions. Application review typically runs 60 to 120 days, and storage magazines must meet ATF separation distance tables. Consumer fireworks must also satisfy Consumer Product Safety Commission rules at 16 CFR Part 1500 and 16 CFR Part 1507, adding third-party testing costs for each product family.

Medical strontium-89 is licensed by the Nuclear Regulatory Commission under 10 CFR Part 35, with agreement states such as Texas and New York administering licences locally. The Food and Drug Administration requires compliance with each approved product presentation, and inspection readiness adds recurring cost. Strontium compounds sit on the EPA's TSCA Inventory, and importing an unlisted substance requires a premanufacture notice that delays market entry by months.

Policy-Created Opportunities in the United States

The Department of Defense's National Defense Stockpile, authorised under the Strategic and Critical Materials Stock Piling Act, creates a procurement channel for strategic strontium compounds used in defence pyrotechnics and electronics. Defense Production Act Title III awards fund domestic critical-mineral processing, opening multi-year contracts for U.S. carbonate refiners that prioritise onshore supply over Chinese material.

Section 45X credits reward domestic ferrite magnet production, creating openings for U.S. magnet makers supplying motors for defence platforms and grid equipment. Separately, FDA-approved strontium-89 radiopharmaceuticals generate recurring demand for domestically licensed isotope supply, opening contracts for NRC-licensed distributors serving hospital networks across multiple states.

Regulatory and Policy Environment

The primary legislation is the Toxic Substances Control Act, as amended by the Frank R. Lautenberg Chemical Safety for the 21st Century Act of 2016, administered by the Environmental Protection Agency's Office of Chemical Safety and Pollution Prevention. Manufacturers and importers must keep substances on the TSCA Inventory, submit Chemical Data Reporting on a four-year cycle, and comply with risk evaluation outcomes for chemicals designated as high priority. The next Chemical Data Reporting window opens in 2028.

Upcoming changes include the Section 232 outcome on processed critical minerals and the USMCA joint review in July 2026, which determines tariff treatment of Mexican celestite. Compared with regional peers, the U.S. framework imposes lighter pre-market burdens than the European Union's REACH regime, which requires registration with the European Chemicals Agency, while Canada's CEPA applies a notification model closer to TSCA.

Long-Term Policy Outlook for U.S. Strontium

By 2032, the USMCA joint review will determine whether Mexican celestite enters duty-free, reshaping sourcing for U.S. ferrite and pyrotechnic buyers. The phase-down of Section 45X credits beginning in 2031 means domestic carbonate economics will depend on whether producers secured capacity before subsidy support declines.

Expect TSCA risk evaluation activity to extend to strontium compounds as the EPA's priority list expands, alongside continued Section 301 duties on Chinese magnets. These changes will shift the market toward domestically certified supply chains, rewarding firms that document TSCA, ATF and NRC compliance across their full supplier base rather than competing on price alone.

Market at a Glance

Leading Market Participants

• Solvay
• Merck KGaA
• Thermo Fisher Scientific
• Arnold Magnetic Technologies
• TDK Corporation
• Proterial
• Ferroxcube
• Ningbo Yunsheng
• Cerac Inc.
• Jubilant Radiopharma